Pediatric Medullary Sponge Kidney
- Author: Howard Trachtman, MD; Chief Editor: Craig B Langman, MD more...
Medullary sponge kidney (MSK) is likely the result of an abnormality in renal development, as evidenced by the occasional presence of embryonal tissue in the affected papillae. Recent findings suggest that medullary sponge kidney may result from disruption of the ureteric bud/metanephric-blastema interface that is critical in normal kidney development.
Medullary sponge kidney is characterized by ectasia and cystic formation in the medullary collecting duct. This characterization contrasts with autosomal recessive polycystic kidney disease and with autosomal dominant polycystic kidney disease, in which cysts predominantly develop along the cortical collecting tubule or the entire nephron, respectively. Medullary cysts give the kidney the gross anatomic appearance of a sponge. In the absence of hematuria, renal calculi, or infection, the disease is an asymptomatic nonprogressive condition. See the images below.
The kidney is the primary organ affected. Ectasia and cystic malformation are present along the intrapyramidal or intrapapillary portion of the medullary collecting duct. Cysts may be heterogeneous in size within one kidney and between the 2 kidneys, ranging in size from 1-3 mm. Cysts may communicate and often contain spherical concretions composed of apatite.
The association of medullary sponge kidney with different malformation conditions suggests that it belongs to the developmental disorders that result from disruption of the ureteric bud-metanephric blastema interface. This is based on the occasional presence of remnant embryonal tissue in the affected papillae. Pathological studies suggest that medullary sponge kidney is due to an obstruction of the fetal-collecting duct or to a structural defect caused by hypercalciuria. Although the cause of medullary sponge kidney is unknown, family occurrence suggests a genetic component.
Medullary sponge kidney has been linked to defects in tubular function, including acidification and concentration. Two patients with medullary sponge kidney in association with distal renal tubular acidosis, late sensorineural hearing loss, and a mutation in the proton pump genes ATP6V1B1 and ATP6V0A4 were described.
In one study, 55 patients with medullary sponge kidney were evaluated for sequence variations in the glial cell-derived neurotrophic factor (GDNF) gene. Two novel variations were found in the heterozygous state in 8 patients. A case-control study confirmed that these 2 alleles were associated with medullary sponge kidney. Interestingly, 5 of the 8 cases were found to be familial in a seemingly dominant pattern of inheritance. This report is interesting because GDNF and its receptor, RET, are involved in renal development. Thus, mutations in GDNF may lead to abnormal kidney morphogenesis that can manifest as medullary sponge kidney.
Medullary sponge kidney may be part of other syndromes and conditions such as Beckwith-Wiedemann syndrome (BWS), hemihypertrophy, Caroli disease, Ehlers-Danlos syndrome, Marfan syndrome, and pyloric stenosis. Medullary sponge kidney may occur in as many as 12.5% of cases of BWS, if congenital hemihypertrophy is part of the clinical picture. Finally, medullary sponge kidney was recently described in a 10-year-old boy with Rabson-Mendenhall syndrome (ie, severe insulin resistance, hyperinsulinemia, postprandial hyperglycemia, growth retardation, and dysmorphic features).
The prevalence rate is 1 case per 5,000-20,000 population. Medullary sponge kidney may be detected in 0.5-1% of asymptomatic individuals who undergo renal imaging studies for assorted clinical indications. In a 2013 study of 50 patients with medullary sponge kidney, based on careful interviews, renal imaging, and biochemical studies, 27 probands with medullary sponge kidney had 59 first- and second-degree relatives of both sexes with medullary sponge kidney in all generations. This is the strongest evidence of familial clustering of the disease with an autosomal dominant pattern of inheritance.
Evidence indicates that worldwide incidence of medullary sponge kidney is similar to that found in the United States.
Morbidity or mortality is not directly related to medullary sponge kidney. In the absence of hematuria, urinary tract infection (UTI), or renal calculi, medullary sponge kidney is usually a nonprogressive asymptomatic condition. Under normal conditions, patients may have a mild urinary-concentrating defect or low-grade proteinuria.
Patients have a higher risk for developing calcium oxalate/apatite or struvite renal calculi. Factors that may contribute to the susceptibility to recurrent calcium urolithiasis include: (1) urine stasis, (2) incomplete renal tubular acidosis (RTA) with a mild defect in urinary acidification and increased urine pH levels, (3) hypocitric aciduria, and (4) hypercalciuria. Patients are usually aged 20-50 years at presentation, although the condition may occur in children younger than 5 years. As many as 20% of adults with kidney stones may have medullary sponge kidney. The lifetime risk of renal stones may be as high as 60% in adults with medullary sponge kidney.
In a recent review of 56 patients with a radiographic diagnosis of medullary sponge kidney, 39 (70%) had nephrolithiasis confirmed by x-ray studies, and, of these, 13 had recurrent episodes. The prevalence of medullary sponge kidney is higher (8.5%) in adults with renal stones compared with the control population (1.5%). Medullary sponge disease is often the cause of asymptomatic stones that are detected during the evaluation of potential kidney donors. The corresponding figure in children is unknown. Among patients with kidney stones, hypercalciuria may occur in 40-50% and recurrent gross hematuria may occur in 10-20%.
Hyperparathyroidism is frequently associated with medullary sponge kidney and was thought to cause the disease and trigger stone formation. However, the urinary findings and clinical features of medullary sponge kidney usually precede the detection of hyperparathyroidism.
Although no evidence indicates that risk of UTIs is higher in patients with medullary sponge kidney, as many as 5% of males and 35% of females have a UTI. These patients do not have an increased frequency of concomitant structural anomalies (eg, vesicoureteral reflux) to account for the occurrence of UTI.
Because patients with medullary sponge have hypercalciuria and incomplete distal RTA, they may be at risk for developing bone disease. In fact, a study of 75 patients with medullary sponge kidney demonstrated that most had either osteopenia or osteoporosis based on bone densitometry T scores between -1.0 and -2.5 (approximately 60%) or <-2.5 (approximately 10%), respectively. The administration of oral potassium citrate supplements led to an increase in urinary pH, reduction in hypercalciuria, and improvement in bone density.
No epidemiologic data indicate that incidence varies among racial or ethnic subgroups.
No evidence indicates that the frequency differs between the sexes. Fewer than 5% of cases are familial, and a clear genetic basis for medullary sponge kidney has not been established. The only genetic pattern observed in select pedigrees is an autosomal dominant type of transmission. Medullary sponge kidney appears to be somewhat more severe in women; the incidence of renal calculi and UTIs in women is higher than in men.
Symptoms occur primarily in adults aged 20-50 years; however, infants as young as 2 years and adolescents have shown clinical symptoms.
Gambaro G, Feltrin GP, Lupo A, et al. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int. 2006 Feb. 69(4):663-70. [Medline].
Carboni I, Andreucci E, Caruso MR, et al. Medullary sponge kidney associated with primary distal renal tubular acidosis and mutations of the H+-ATPase genes. Nephrol Dial Transplant. 2009 Sep. 24(9):2734-8. [Medline].
Torregrossa R, Anglani F, Fabris A, et al. Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. Clin J Am Soc Nephrol. 2010 Jul. 5(7):1205-10. [Medline].
Harris AM, Hall B, Kriss VM, Fowlkes JL, Kiessling SG. Rabson-Mendenhall syndrome: medullary sponge kidney, a new component. Pediatr Nephrol. 2007 Dec. 22(12):2141-4. [Medline].
Fabris A, Lupo A, Ferraro PM, Anglani F, Pei Y, Danza FM, et al. Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. Kidney Int. 2013 Feb. 83(2):272-7. [Medline].
Pritchard MJ. Medullary sponge kidney: causes and treatments. Br J Nurs. 2010 Aug 12-Sep 8. 19(15):972-6. [Medline].
McPhail EF, Gettman MT, Patterson DE, Rangel LJ, Krambeck AE. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. Urology. 2012 Feb. 79(2):277-81. [Medline].
Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011 Aug. 26(8):2695-700. [Medline]. [Full Text].
Fabris A, Bernich P, Abaterusso C, Marchionna N, Canciani C, Nouvenne A. Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol. 2009 Dec. 4(12):1974-9. [Medline].
Fabris A, Lupo A, Bernich P, et al. Long-term treatment with potassium citrate and renal stones in medullary sponge kidney. Clin J Am Soc Nephrol. 2010 Sep. 5(9):1663-8. [Medline].
Abeshouse BS, Abeshouse GA. Sponge kidney: a review of the litrature and a report of five cases. J Urol. 1960 Aug. 84:252-67. [Medline].
Avner ED. Medullary sponge kidney. Greenber A, Cheung AK, Coffman TM, et al, eds. NKF Primer on Kidney Disease. 1997.
Osther PJ, Mathiasen H, Hansen AB, et al. Urinary acidification and urinary excretion of calcium and citrate in women with bilateral medullary sponge kidney. Urol Int. 1994. 52(3):126-30. [Medline].
Patriquin HB, O'Regan S. Medullary sponge kidney in childhood. AJR Am J Roentgenol. 1985 Aug. 145(2):315-9. [Medline].
[Guideline] Tiselius HG, Alken P, Buck C, Gallucci M, Knoll T, Sarica K, Turk C. Guidelines on urolithiasis. Arnhem, The Netherlands: European Association of Urology (EAU); 2008 Mar. [Full Text].